Kennedy Capital Management’s DexCom DXCM Stock Holding History

Kennedy Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.56M	Buy	72,687 +143	+0.2%	+$9.96K	0.1%	312
2025 Q4	$4.81M	Buy	72,544 +62,077	+593%	+$4.01M	0.1%	305
2025 Q3	$704K	Sell	10,467 -8,063	-44%	-$638K	0.02%	521
2025 Q2	$1.62M	Sell	18,530 -12,440	-40%	-$975K	0.04%	467
2025 Q1	$2.11M	Buy	+30,970	New	+$2.53M	0.05%	430
2024 Q4	–	Sell	-47,528	Closed	-$3.19M	–	693
2024 Q3	$3.19M	Buy	47,528 +26,762	+129%	+$2.2M	0.07%	408
2024 Q2	$2.35M	Buy	20,766 +8,584	+70%	+$1.09M	0.05%	486
2024 Q1	$1.69M	Buy	+12,182	New	+$1.53M	0.03%	549

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kennedy Capital Management's DXCM Position: Q1 2026 in Review

Kennedy Capital Management increased its DexCom (DXCM) stake by 0.2% in Q1 2026, buying an estimated $9.96K and bringing the position to 72,687 shares worth $4.56M. The position accounts for 0.1% of the portfolio, ranked #312.

Kennedy Capital Management first reported a position in DXCM in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.81M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Kennedy Capital Management held 72,687 shares of DexCom worth $4.56M as of Q1 2026.
Kennedy Capital Management bought 143 DexCom shares in Q1 2026, an estimated $9.96K.
DexCom made up 0.1% of Kennedy Capital Management's portfolio in Q1 2026, its #312 holding.
Kennedy Capital Management first reported a position in DexCom in Q1 2024 and has held it in 8 quarters since.
Kennedy Capital Management's DexCom position peaked at $4.81M in Q4 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.